2,4-pyridinedicarboxylic acid and Osteogenic Sarcoma

2,4-pyridinedicarboxylic acid has been researched along with Osteogenic Sarcoma in 1 studies

Research

Studies (1)

Timeframe	Studies, this research(%)	All Research%
pre-1990	0 (0.00)	18.7374
1990's	0 (0.00)	18.2507
2000's	0 (0.00)	29.6817
2010's	1 (100.00)	24.3611
2020's	0 (0.00)	2.80

Authors

Authors	Studies
Cloos, P; Gajhede, M; Helgstrand, C; Helin, K; Kastrup, JS; Kristensen, LH; Lees, M; Nielsen, AL; Olsen, L	1

Other Studies

1 other study(ies) available for 2,4-pyridinedicarboxylic acid and Osteogenic Sarcoma

Article	Year
Studies of H3K4me3 demethylation by KDM5B/Jarid1B/PLU1 reveals strong substrate recognition in vitro and identifies 2,4-pyridine-dicarboxylic acid as an in vitro and in cell inhibitor. The FEBS journal, 2012, Volume: 279, Issue:11 Topics: Amino Acid Sequence; Baculoviridae; Cell Line, Tumor; Chromatin; Enzyme Inhibitors; Histone Methyltransferases; Histone-Lysine N-Methyltransferase; Histones; Humans; Jumonji Domain-Containing Histone Demethylases; Kinetics; Lysine; Models, Molecular; Molecular Sequence Data; Nuclear Proteins; Osteosarcoma; Protein Isoforms; Pyridines; Recombinant Proteins; Repressor Proteins; Substrate Specificity; Transfection	2012

Article

Year

Studies of H3K4me3 demethylation by KDM5B/Jarid1B/PLU1 reveals strong substrate recognition in vitro and identifies 2,4-pyridine-dicarboxylic acid as an in vitro and in cell inhibitor.

The FEBS journal, 2012, Volume: 279, Issue:11

Topics: Amino Acid Sequence; Baculoviridae; Cell Line, Tumor; Chromatin; Enzyme Inhibitors; Histone Methyltransferases; Histone-Lysine N-Methyltransferase; Histones; Humans; Jumonji Domain-Containing Histone Demethylases; Kinetics; Lysine; Models, Molecular; Molecular Sequence Data; Nuclear Proteins; Osteosarcoma; Protein Isoforms; Pyridines; Recombinant Proteins; Repressor Proteins; Substrate Specificity; Transfection

2012